Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trials. (2023)
Attributed to:
Respiratory infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2023.06.037
PubMed Identifier: 37355453
Publication URI: http://europepmc.org/abstract/MED/37355453
Type: Journal Article/Review
Volume: 41
Parent Publication: Vaccine
Issue: 31
ISSN: 0264-410X